SpotLight Proteomics-A IgG-Enrichment Phenotype Profiling Approach with Clinical Implications

Area of Science:

• Immunology
• Proteomics
• Respiratory Medicine

Background:

• Sarcoidosis is a systemic interstitial lung disease with unknown causes.
• Accurate diagnostics are needed to understand sarcoidosis pathology and subtypes.
• Less invasive diagnostic methods are crucial for patient care.

Purpose of the Study:

• To evaluate SpotLight proteomics for differentiating sarcoidosis phenotypes.
• To assess the utility of serum and bronchoalveolar lavage fluid (BALF) in distinguishing controls, Löfgren's syndrome (LS), and non-Löfgren's syndrome (nonLS).

Main Methods:

• SpotLight proteomics was applied to IgG-enriched samples from serum and BALF of controls, LS, and nonLS patients.
• High-resolution mass spectrometry and label-free quantification were employed.
• Univariate and multivariate statistical analyses, including orthogonal partial least squares discriminant analysis (OPLS-DA), were performed.

Main Results:

• Significant proteomic differences were observed between control and sarcoidosis BALF samples.
• Serum proteomic profiles also reflected differences between controls and sarcoidosis patients (p = 0.0007).
• SpotLight proteomics successfully differentiated LS from nonLS in both BALF and serum (p = 0.006).
• Key differentiating factors included Fc-regulation, IgG-Fab region features, and novel peptide variants, primarily related to IgG specificity.

Conclusions:

• SpotLight proteomics demonstrates analytical utility in distinguishing sarcoidosis from controls.
• The method shows potential for differentiating sarcoidosis phenotypes using serum samples.
• This approach may lead to less invasive diagnostic tools for sarcoidosis subtypes.